Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
2-Phenylmelatonin is a melatonin 1 (MT1) and MT2 receptor mixed partial agonist and antagonist.1,2,3 It selectively binds to MT1 and MT2 receptors (Kis = 0.02 and 0.09 nM, respectively, in HEK293 cells expressing the human receptors) over the MT3 receptor (Ki = 33 nM in hamster brain membranes).1 2-Phenylmelatonin induces [35S]GTPγS binding to NIH3T3 cell membranes expressing the human MT2 receptor (EC50 = 0.058 nM).2 It induces contractions (EC50 = 0.5 nM) and inhibits melatonin-induced contractions in isolated guinea pig proximal colon strips when used at a concentration of 0.1 nM.3 2-Phenylmelatonin reduces intraocular pressure in rabbits (pD2 = 8.7).4
WARNING This product is not for human or veterinary use.
1. Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2. Biochem. Pharmacol. 61(11), 1369-1379 (2001).
2. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: Evidence for agonist activity of some mt1-
3. 2-
4. Ocular hypotensive effects of melatonin receptor agonists in the rabbit: Further evidence for an MT3 receptor. Br. J. Pharmacol. 138(5), 831-836 (2003).